Anti-Human H1 Complex Recombinant Antibody
-
产品编号
YR1082
-
别名
科研级 Derlotuximab ( 地洛妥单抗, 地洛昔单抗 ), Anti-H1 Complex Recombinant Antibody, Research Grade Derlotuximab
-
规格
- 1mg
- 5mg
Alias | 科研级 Derlotuximab ( 地洛妥单抗, 地洛昔单抗 ), Anti-H1 Complex Recombinant Antibody, Research Grade Derlotuximab |
Catalog Number | YR1082 |
Molecular Name | Derlotuximab |
Size | 1mg, 5mg |
Clonity | Monoclonal |
Purity | >95% as determined by SDS-PAGE |
Concentration | 1mg/ml |
Antibody Isotype | IgG1 Kappa |
Formulation | PBS, pH7.5 |
Background | Daratumumab, sold under the brand name Darzalex, is an anti-cancer medication. It binds to CD38, which is overexpressed in multiple myeloma cells. Daratumumab was originally developed by Genmab, but it is now being jointly developed by Genmab along with the Johnson & Johnson subsidiary Janssen Biotech, which acquired worldwide commercialization rights to the drug from Genmab. |
CAS Number | 340013-96-9 |
Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
Remarks | This product is for research use only. |
Shipping Condition | Shipped on ice packs. |
Target | H1 complex[Homo sapiens] |